Lentuo International Inc (ADR) (LAS), Nam Tai Electronics, Inc. (NTE), China Hgs Real Estate Inc (HGSH) Among The Top Five Losers On Monday

Editor’s note: Related tickers: Lentuo International Inc (ADR) (NYSE:LAS),  Nam Tai Electronics, Inc. (NYSE:NTE), China Hgs Real Estate Inc (NASDAQ:HGSH), Greenway Medical Technologies, Inc. (NYSE:GWAY), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Even though there are price gainers and volume leaders, the top losers must also be watched. On Monday, the top five losers are: Lentuo International Inc (ADR) (NYSE:LAS),  Nam Tai Electronics, Inc. (NYSE:NTE), China Hgs Real Estate Inc (NASDAQ:HGSH), Greenway Medical Technologies, Inc. (NYSE:GWAY), and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX),

Lentuo International Inc (ADR) (NYSE:LAS) slid by 31.30% to $1.80 in deals worth $370,900. According to a statement on PRNewswire, Lentuo International Inc (ADR) (NYSE:LAS) today posted the financial results for the fourth quarter of 2012 and for the entire last year. The revenue in the fourth quarter fell by 15.4% on the year to $140.8 million, while the net loss totalled $3.9 million, compared to a profit of $2.5 million. Over the whole 2012, the revenue grew by 7.5% to $524.1 million, the statement added.

Nam Tai Electronics, Inc. (NYSE:NTE)

In turnover worth almost $7.4 million, Nam Tai Electronics, Inc. (NYSE:NTE) has lost 29.48% to $7.99. Today, Nam Tai Electronics, Inc. (NYSE:NTE) released its financial results for the first three months of 2013. The net sales advanced to $177.5 million, higher compared to $87.8 million in the first quarter of the previous year. The net income totalled almost $5.0 million, against a loss of $3.6 million, Nam Tai Electronics, Inc. (NYSE:NTE) said in a statement.

China Hgs Real Estate Inc (NASDAQ:HGSH) declined by 25.51% to $9.11. China Hgs Real Estate Inc (NASDAQ:HGSH) is specialized in real estate development, construction and sale of residential apartments, parking as well as commercial properties.

Greenway Medical Technologies, Inc. (NYSE:GWAY) fell by 19.07% to $12.99 in turnover of about $887,900.  In a statement issued today, Greenway Medical Technologies, Inc. (NYSE:GWAY), has reviewed its outlook for the fiscal year that will end on June 30, 2013. The company forecasts a revenue between $132 million and $134 million and an adjusted EBITDA of between %5.8 million to $6.8 million.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) decreased by 18.86% to $1.85 in deals worth $3.2 million. The Street said in a story today that  Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) could suffer after Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) announced about signing a partnership agreement for the development of Pfizer Inc. (NYSE:PFE)’s ertugliflozin which is being evaluated for the cure of type 2 diabetes. Since Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is designing a similar drug, LX4211, it could have some difficulties finding a partner to help cover the costs of research, The Street said.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!